Literature DB >> 20018925

Multidrug resistance-associated protein 4 (MRP4) gene polymorphisms and treatment response in adult acute lymphoblastic leukemia.

Monika Brüggemann, Heiko Trautmann, Dieter Hoelzer, Michael Kneba, Nicola Gökbuget, Thorsten Raff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20018925     DOI： 10.1182/blood-2009-09-243741

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

Review 1.  Pharmacogenetics of drug metabolizing enzymes and transporters: effects on pharmacokinetics and pharmacodynamics of anticancer agents.

Authors:  Norman H Lee
Journal:  Anticancer Agents Med Chem       Date:  2010-10-01       Impact factor: 2.505

Review 2.  Inherited genetic variation in childhood acute lymphoblastic leukemia.

Authors:  Takaya Moriyama; Mary V Relling; Jun J Yang
Journal:  Blood       Date:  2015-05-21       Impact factor: 22.113

Review 3.  Modeling normal and malignant human hematopoiesis in vivo through newborn NSG xenotransplantation.

Authors:  Fumihiko Ishikawa
Journal:  Int J Hematol       Date:  2013-11-21       Impact factor: 2.490

4.  Lack of the multidrug transporter MRP4/ABCC4 defines the PEL-negative blood group and impairs platelet aggregation.

Authors:  Slim Azouzi; Mahmoud Mikdar; Patricia Hermand; Emilie-Fleur Gautier; Virginie Salnot; Alexandra Willemetz; Gaël Nicolas; Cédric Vrignaud; Alexandre Raneri; Patrick Mayeux; Christine Bole-Feysot; Patrick Nitschké; Jean-Pierre Cartron; Yves Colin; Olivier Hermine; Gabriele Jedlitschky; Marc Cloutier; Jessica Constanzo-Yanez; Carole Ethier; Nancy Robitaille; Maryse St-Louis; Caroline Le Van Kim; Thierry Peyrard
Journal:  Blood       Date:  2020-02-06       Impact factor: 22.113
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.